logo
Select company
Select metric
-63.14%EBITDA Margin
VS
Market
14
Sector
41
Industry
16
History
85
$ 5.08Close
$ 2.82 - $ 16.95 52-Week Range
Ticker Information

Ticker

EKSO

Company Name

EKSO BIONICS HOLDINGS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

EKSO BIONICS HOLDINGS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EKSO - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -9.25M-63.14%$ 14.65M
3/31/2025$ -8.93M-50.89%$ 17.54M
12/31/2024$ -9.45M-52.74%$ 17.93M
9/30/2024$ -8.97M-50.73%$ 17.68M
6/30/2024$ -10.34M-56.95%$ 18.16M
3/31/2024$ -12.3M-68.67%$ 17.91M
12/31/2023$ -13.2M-72.2%$ 18.28M
9/30/2023$ -13.57M-79.88%$ 16.98M
6/30/2023$ -14.71M-93.65%$ 15.71M
3/31/2023$ -13.42M-92.78%$ 14.47M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EKSO BIONICS HOLDINGS INC's latest trailing twelve months (TTM) EBITDA % stands at -132.89%.
  • Over the past 5 years, EKSO BIONICS HOLDINGS INC's average EBITDA % has been -89.7%.
  • The median EBITDA % for EKSO BIONICS HOLDINGS INC during this period was -82.56%
  • EKSO BIONICS HOLDINGS INC reached its highest EBITDA % over the past 5 years at -50.73%.
  • The lowest EBITDA % recorded by EKSO BIONICS HOLDINGS INC in the same timeframe -174.43%

EKSO BIONICS HOLDINGS INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
CARM : CARISMA THERAPEUTICS INC -424.25%VSEE : VSEE HEALTH INC -554.19%LUCY : INNOVATIVE EYEWEAR INC -383.4%CSCIF : COSCIENS BIOPHARMA INC -172.1%EVOK : EVOKE PHARMA INC -37.76%NXGL : NEXGEL INC -19.58%POAI : PREDICTIVE ONCOLOGY INC -847.68%BNGO : BIONANO GENOMICS INC -222.04%SNOA : SONOMA PHARMACEUTICALS INC -20.23%MSPR : MSP RECOVERY INC -882.84%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for EKSO BIONICS HOLDINGS INC is calculated as follows: EBITDA [ $ -13.75M ] / Revenues [ $ 10.35M ]
(=) EBITDA % [ -132.89% ]

EKSO - EBITDA Margin, Last 5 years

-174.43%

Minimum

Mar 31, 2021

-50.73%

Maximum

Sep 30, 2024

-89.7%

Average

-82.56%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%